Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2011
Pharmacology, Toxicology and Pharmaceutics journal rankings 2011
49 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 49 ranked journals in 2011. The median OJR rose 0.08 on 2010 to 1.03, above the world average of 1.00; Q1 starts at OJR 1.60. The top three are Expert Opinion on Drug Delivery, Current Drug Metabolism, and Pharmaceutical Research.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences49 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 2.73Q1 | 6.51 1.46 up from 2010 | 289 | 14% | — | ||
2Current Drug MetabolismBentham Science Publishers · Netherlands | 2.63Q1 | 4.92 0.02 down from 2010 | 242 | 15% | — | ||
3Pharmaceutical ResearchSpringer Science+Business Media · United States | 2.46Q1 | 4.71 0.33 down from 2010 | 794 | 28% | $4,690 | ||
4European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 2.27Q1 | 3.61 0.47 down from 2010 | 690 | 11% | $4,210 | ||
5The Pharmacogenomics JournalSpringer Nature · United Kingdom | 2.17Q1 | 5.31 0.99 up from 2010 | 183 | 44% | $4,890 | ||
6Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.99Q1 | 3.79 0.28 down from 2010 | 372 | 13% | — | ||
7Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.95Q1 | 3.96 0.13 up from 2010 | 908 | 28% | $3,500 | ||
8International Journal of PharmaceuticsElsevier BV · Netherlands | 1.95Q1 | 3.88 0.33 up from 2010 | 1,669 | 10% | $4,650 | ||
9Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 1.91Q1 | 4.10 0.56 down from 2010 | 358 | 32% | — | ||
10European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.76Q1 | 3.52 0.39 up from 2010 | 589 | 8% | $3,070 | ||
11Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 1.70Q1 | 3.04 1.00 down from 2010 | 36 | 0% | — | ||
12PharmacogenomicsFuture Medicine · United Kingdom | 1.67Q1 | 3.50 0.19 down from 2010 | 548 | 16% | — | ||
13Drug SafetyAdis, Springer Healthcare · New Zealand | 1.60Q1 | 4.18 1.41 up from 2010 | 457 | 6% | $4,990 | ||
14Expert Opinion on Drug SafetyTaylor & Francis · United Kingdom | 1.54Q2 | 3.38 0.17 up from 2010 | 242 | 9% | — | ||
15XenobioticaTaylor & Francis · United Kingdom | 1.32Q2 | 1.90 0.72 down from 2010 | 304 | 12% | — | ||
16Drug Metabolism and PharmacokineticsElsevier BV · Japan | 1.24Q2 | 2.43 0.64 down from 2010 | 226 | 2% | $3,580 | ||
17Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.21Q2 | 2.25 0.21 up from 2010 | 307 | 41% | $4,823 | ||
18Recent Patents on Drug Delivery & FormulationBentham Science Publishers · Netherlands | 1.19Q2 | 2.21 0.48 up from 2010 | 67 | 5% | — | ||
19Forensic ToxicologySpringer Science+Business Media · Japan | 1.13Q2 | 2.96 1.31 up from 2010 | 68 | 0% | $2,990 | ||
20Biopharmaceutics & Drug DispositionWiley · United Kingdom | 1.08Q2 | 2.35 0.65 up from 2010 | 147 | 24% | $3,800 | ||
21Drug Testing and AnalysisWiley · United States | 1.07Q2 | 2.52 0.62 up from 2010 | 195 | 8% | $4,440 | ||
22Drug metabolism and drug interactionsDe Gruyter · Germany | 1.07Q2 | 0.88 0.94 down from 2010 | 43 | 6% | — | ||
23Journal of Pharmaceutical InnovationSpringer Science+Business Media · United Kingdom | 1.03Q2 | 1.07 0.91 down from 2010 | 70 | 9% | $3,990 | ||
24Current Drug DeliveryBentham Science Publishers · Netherlands | 1.03Q2 | 1.94 0.03 up from 2010 | 156 | 0% | — | ||
25AAPS PharmSciTechSpringer Science+Business Media · United States | 1.03Q2 | 1.91 0.36 up from 2010 | 565 | 100% | $4,190 | ||
26Clinical and Translational ScienceOAWiley · United Kingdom | 1.01Q3 | 2.36 0.92 up from 2010 | 192 | 94% | $3,630 | ||
27Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.97Q3 | 2.15 0.50 up from 2010 | 579 | 3% | $3,660 | ||
28Journal of MicroencapsulationTaylor & Francis · United Kingdom | 0.94Q3 | 1.77 0.30 up from 2010 | 263 | 7% | — | ||
29Recent Patents on NanotechnologyBentham Science Publishers · Netherlands | 0.92Q3 | 1.73 0.84 up from 2010 | 69 | 7% | — | ||
30Drug DeliveryOATaylor & Francis · United Kingdom | 0.88Q3 | 1.81 0.33 up from 2010 | 220 | 100% | $2,864 | ||
31Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.75Q3 | 1.63 0.12 up from 2010 | 595 | 4% | — | ||
32Drug Metabolism LettersBentham Science Publishers · Netherlands | 0.70Q3 | 1.05 0.15 down from 2010 | 112 | 11% | — | ||
33Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.61Q3 | 1.46 0.29 down from 2010 | 228 | 38% | — | ||
34Current Chemical BiologyBentham Science Publishers · Netherlands | 0.60Q3 | 1.70 0.43 up from 2010 | 154 | 14% | — | ||
35Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.60Q3 | 1.04 0.17 up from 2010 | 343 | 4% | — | ||
| 0.57Q3 | 0.90 0.10 up from 2010 | 48 | 0% | — | |||
37Therapeutic DeliveryFuture Science Ltd · United Kingdom | 0.46Q3 | 1.04no 2010 value | 80 | 14% | — | — | |
38Dissolution TechnologiesUnited States | 0.46Q4 | 0.71 0.08 down from 2010 | 90 | 80% | — | ||
39Indian Journal of Pharmaceutical Education and ResearchAssociation of Pharmaceutical Teachers of India · India | 0.43Q4 | 0.66 0.66 up from 2010 | 49 | — | — | ||
40Journal of Drug Delivery Science and TechnologyElsevier BV · France | 0.40Q4 | 0.92 0.25 up from 2010 | 174 | 3% | $3,810 | ||
41YAKUGAKU ZASSHIOAPharmaceutical Society of Japan · Japan | 0.33Q4 | 0.65 0.07 down from 2010 | 648 | 100% | — | ||
42Current Drug TherapyBentham Science Publishers · Netherlands | 0.33Q4 | 0.60 0.14 down from 2010 | 80 | 8% | — | ||
43European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.32Q4 | 0.52 0.06 up from 2010 | 94 | 4% | $2,690 | ||
44Brazilian Journal of Pharmaceutical SciencesOAUniversity of São Paulo · Brazil | 0.32Q4 | 0.50 0.31 up from 2010 | 211 | 100% | — | ||
45Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 0.27Q4 | 0.37 0.02 down from 2010 | 449 | 100% | $1,207 | ||
46Annales de Toxicologie AnalytiqueElsevier BV · France | 0.18Q4 | 0.28 0.21 down from 2010 | 97 | 97% | $3,140 | ||
47The Open Addiction JournalOABentham Science Publishers · Netherlands | 0.17Q4 | 0.32 0.25 up from 2010 | 32 | 100% | — | ||
| 0.14Q4 | 0.26 0.19 up from 2010 | 78 | 100% | — | |||
49Journal of Pharmaceutical InvestigationSpringer Science+Business Media · South Korea | 0.09Q4 | 0.27no 2010 value | 55 | 0% | $3,890 |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
24 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 49
- Window papers (baseline)
- 49,553 +29.9% from indicator year 2008
- Median OJR
- 1.03 +8.3% from indicator year 2008
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.